- Home
- XOM vs NVO Comparison
XOM vs NVO Comparison
Compare XOM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOM
- NVO
- Stock Information
- Founded
- XOM 1870
- NVO 1923
- Country
- XOM United States
- NVO Denmark
- Employees
- XOM N/A
- NVO N/A
- Industry
- XOM Integrated oil Companies
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XOM Energy
- NVO Health Care
- Exchange
- XOM Nasdaq
- NVO Nasdaq
- Market Cap
- XOM 522.9B
- NVO 530.0B
- IPO Year
- XOM N/A
- NVO N/A
- Fundamental
- Price
- XOM $117.84
- NVO $110.16
- Analyst Decision
- XOM Buy
- NVO Strong Buy
- Analyst Count
- XOM 20
- NVO 6
- Target Price
- XOM $130.22
- NVO $139.33
- AVG Volume (30 Days)
- XOM 13.8M
- NVO 6.0M
- Earning Date
- XOM 11-01-2024
- NVO 11-06-2024
- Dividend Yield
- XOM 3.36%
- NVO 1.32%
- EPS Growth
- XOM N/A
- NVO 26.84
- EPS
- XOM 8.03
- NVO 3.17
- Revenue
- XOM $343,818,000,000.00
- NVO $40,469,178,712.00
- Revenue This Year
- XOM $4.32
- NVO $25.02
- Revenue Next Year
- XOM N/A
- NVO $20.47
- P/E Ratio
- XOM $14.68
- NVO $34.07
- Revenue Growth
- XOM N/A
- NVO 26.15
- 52 Week Low
- XOM $95.77
- NVO $94.73
- 52 Week High
- XOM $126.34
- NVO $148.15
- Technical
- Relative Strength Index (RSI)
- XOM 43.12
- NVO 54.78
- Support Level
- XOM $116.82
- NVO $104.96
- Resistance Level
- XOM $123.21
- NVO $107.70
- Average True Range (ATR)
- XOM 1.81
- NVO 1.75
- MACD
- XOM -0.35
- NVO 1.18
- Stochastic Oscillator
- XOM 12.60
- NVO 96.90
About XOM Exxon Mobil Corporation
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one of the world's largest refiners with a total global refining capacity of 4.5 million barrels of oil per day and is one of the world's largest manufacturers of commodity and specialty chemicals.
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.